Form 4: Verrica Pharmaceuticals CEO Ted White Sells Shares to Cover Tax Obligations

Verrica Pharmaceuticals' CEO, Ted White, sold shares of common stock to cover statutory tax withholding obligations related to the settlement of restricted stock units.

Summary

• Ted White, the President and CEO of Verrica Pharmaceuticals, sold shares of the company's common stock on August 26 and 27, 2024.
• The sales were executed to cover statutory tax withholding obligations associated with the settlement of restricted stock units.
• On August 26, 2024, 24,979 shares were sold at a weighted average price of $2.66, with prices ranging from $2.53 to $2.83.
• On August 27, 2024, 9,021 shares were sold at a weighted average price of $2.46, with prices ranging from $2.40 to $2.53.
• Following these transactions, White directly owns 215,967 shares of Verrica Pharmaceuticals' common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects a routine transaction to cover tax obligations, which is neither particularly positive nor negative for the company's outlook.

Industry Context

Executive stock sales for tax obligations are a common practice, particularly after the vesting of restricted stock units. This is a routine transaction and doesn't necessarily indicate a change in the executive's confidence in the company.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates